Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Ribavirin Does Not Impair the Suppressive Activity of Foxp3(+)CD4(+)CD25(+) Regulatory T Cells.

Lee J, Choi YS, Shin EC.

Immune Netw. 2013 Feb;13(1):25-9. doi: 10.4110/in.2013.13.1.25. Epub 2013 Feb 28.

2.

CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.

Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH.

J Immunol. 2009 Dec 1;183(11):7602-10. doi: 10.4049/jimmunol.0901881. Epub 2009 Nov 16.

3.

Ribavirin modulates the conversion of human CD4(+)  CD25(-) T cell to CD4(+)  CD25(+)  FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell.

Kobayashi T, Nakatsuka K, Shimizu M, Tamura H, Shinya E, Atsukawa M, Harimoto H, Takahashi H, Sakamoto C.

Immunology. 2012 Nov;137(3):259-70. doi: 10.1111/imm.12005.

4.

Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease.

Cook L, Munier CML, Seddiki N, van Bockel D, Ontiveros N, Hardy MY, Gillies JK, Levings MK, Reid HH, Petersen J, Rossjohn J, Anderson RP, Zaunders JJ, Tye-Din JA, Kelleher AD.

J Allergy Clin Immunol. 2017 Mar 8. pii: S0091-6749(17)30343-3. doi: 10.1016/j.jaci.2017.02.015. [Epub ahead of print]

5.

Dynamic changes in CD45RA(-)Foxp3(high) regulatory T-cells in chronic hepatitis C patients during antiviral therapy.

Li Z, Ping Y, Yu Z, Wang M, Yue D, Zhang Z, Li J, Zhang B, Shi X, Zhang Y.

Int J Infect Dis. 2016 Apr;45:5-12. doi: 10.1016/j.ijid.2016.02.006. Epub 2016 Feb 11.

6.

Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.

Tsaknaridis L, Spencer L, Culbertson N, Hicks K, LaTocha D, Chou YK, Whitham RH, Bakke A, Jones RE, Offner H, Bourdette DN, Vandenbark AA.

J Neurosci Res. 2003 Oct 15;74(2):296-308.

PMID:
14515359
7.

Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.

Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.

Arthritis Rheum. 2008 Mar;58(3):801-12. doi: 10.1002/art.23268.

8.

Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.

Claassen MA, de Knegt RJ, Janssen HL, Boonstra A.

J Virol. 2011 Jun;85(11):5323-30. doi: 10.1128/JVI.02551-10. Epub 2011 Mar 30.

9.

Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets.

Schuler PJ, Harasymczuk M, Schilling B, Lang S, Whiteside TL.

J Immunol Methods. 2011 Jun 30;369(1-2):59-68. doi: 10.1016/j.jim.2011.04.004. Epub 2011 Apr 13.

10.

Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting hepatitis E.

Rathod SB, Das R, Thanapati S, Arankalle VA, Tripathy AS.

J Viral Hepat. 2014 Feb;21(2):141-51. doi: 10.1111/jvh.12125. Epub 2013 Jul 1.

PMID:
24383927
11.

Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C.

Langhans B, Nischalke HD, Arndt S, Braunschweiger I, Nattermann J, Sauerbruch T, Spengler U.

PLoS One. 2012;7(7):e42094. doi: 10.1371/journal.pone.0042094. Epub 2012 Jul 27.

12.

Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.

Walter GJ, Evans HG, Menon B, Gullick NJ, Kirkham BW, Cope AP, Geissmann F, Taams LS.

Arthritis Rheum. 2013 Mar;65(3):627-38. doi: 10.1002/art.37832.

13.

Human antigen-specific CD4⁺ CD25⁺ CD134⁺ CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses.

Seddiki N, Cook L, Hsu DC, Phetsouphanh C, Brown K, Xu Y, Kerr SJ, Cooper DA, Munier CM, Pett S, Ananworanich J, Zaunders J, Kelleher AD.

Eur J Immunol. 2014 Jun;44(6):1644-61. doi: 10.1002/eji.201344102. Epub 2014 Apr 29.

14.

Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3.

Zheng Y, Manzotti CN, Burke F, Dussably L, Qureshi O, Walker LS, Sansom DM.

J Immunol. 2008 Aug 1;181(3):1683-91.

15.

[The phenotype and function of CD4+ CD25+ regulatory T cells in hepatitis B patients].

Fu JL, Xu DP, Shi M, Zhang H, Jin L, Tang ZR, Wang FS.

Zhonghua Nei Ke Za Zhi. 2006 Aug;45(8):642-5. Chinese.

PMID:
17074148
16.

Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.

Zhai N, Chi X, Li T, Song H, Li H, Jin X, Crispe IN, Su L, Niu J, Tu Z.

Cell Mol Immunol. 2015 Nov;12(6):743-9. doi: 10.1038/cmi.2014.119. Epub 2014 Dec 22.

17.

Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.

Schuler PJ, Schilling B, Harasymczuk M, Hoffmann TK, Johnson J, Lang S, Whiteside TL.

Eur J Immunol. 2012 Jul;42(7):1876-85. doi: 10.1002/eji.201142347. Epub 2012 Jun 18.

18.

Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C.

Hao C, Zhou Y, He Y, Fan C, Sun L, Wei X, Wang L, Peng M, Wang P, Lian J, Jia Z.

Immunology. 2014 Dec;143(4):531-8. doi: 10.1111/imm.12330.

19.

Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin.

Oliveira IS, Carvalho LP, Schinoni MI, Paraná R, Atta AM, Atta ML.

Microb Pathog. 2016 Feb;91:155-60. doi: 10.1016/j.micpath.2015.12.007. Epub 2015 Dec 21.

PMID:
26718098
20.

Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma.

Han Y, Wu J, Bi L, Xiong S, Gao S, Yin L, Jiang L, Chen C, Yu K, Zhang S.

PLoS One. 2011;6(12):e28649. doi: 10.1371/journal.pone.0028649. Epub 2011 Dec 9.

Supplemental Content

Support Center